Home / Markets / Capital Market News / Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Last Updated : Aug 30 2024 | 12:31 PM IST

Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and pathological services business of Vimta Labs.

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Eraaya Lifespaces completes acquisition of Ebix Inc.

Jai Corp board OKs Rs 118-cr share buyback

RVNL jumps after bagging LoA worth Rs 202-cr railway project

Market hits fresh life high; Nifty scales above 25,200

RBI cautions public against fraudulent activities in its name

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 30 2024 | 12:17 PM IST